José Baños

Learn More
BACKGROUND In-stent restenosis is an increasing clinical problem. Discordant results have been published regarding the risk of recurrent restenosis after repeat angioplasty for the treatment of in-stent restenosis. METHODS AND RESULTS One hundred three consecutive patients (107 vessels) underwent repeat percutaneous intervention for the treatment of(More)
AIM To evaluate the risks and the significance of the use of an anti-GPIIb/IIIa, in this case Eptifibatide, during angioplasty following presumed failure of thrombolysis in the acute phase of myocardial infarction. METHOD Patients thrombolyzed following MI < 6 hours. Presumed failure of reperfusion with full dose thrombolysis. Analysis evaluated the(More)
  • 1